Studien | Der Arzneimittelbrief

AFFIRM

Promoting Awareness Fetal Movements to Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial

AFFIRM

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

AFFIRM-AHF

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

AFI

Atrial Fibrillation Investigators

AFIB

Atrial Fibrillation Investigation with Bidisomide

AFIB-ICU

Atrial FIBrillation in the ICU

AFIRE

Atrial Fibrillation and Ischemic Events with Rivaroxaban in patients with stable coronary artery disease

AFIST

Atrial Fibrillation Suppression Trial

AFIST III

Atrial Fibrillation Suppression Trial III

AFIT

Armed Forces Institute of Transfusion

AFIT

Atrial Fibrillation Intervention Trial

AFLOAT

Assessment of Flecainide to Lower the PFO closure risk of Atrial fibrillation or Tachycardia

AFLY5

Active for Life Year 5

AFNET

Atrial Fibrillation NETwork

AFNOR

The Atrial Fibrillation in Norway

AFORRD

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes

AFR-PRELIEVE

Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

AFREGS

Armed Forces REGression Study

AFRICARhE

Monoclonal RhD prophylaxis: high time to evaluate efficacy

AFRIM

Appropriate Fluid Resuscitation In Malnutrition

AFRINEST

African Neonatal Sepsis Trial

AFTER

Aspirin/Anticoagulants Following Thrombolysis with Eminase in Recurrent infarction

After Eighty Study

AfterROSC

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest

AFTherapy

Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation

AFUGEM GERCOR

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma

AGAIN

Arterial Glyceryl Trinitrate in Acute Ischemic Stroke after Thrombectomy for Neuroprotection

AGATA

Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion

AGATHA

Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease

AGATHA-ME

Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease-Middle East

AGAVE-201

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

AGCH

Acute Geriatric Community Hospital in the Netherlands

AGCTG

Australian and New Zealand Germ Cell Trial Group

AgeCoDe

German study on Ageing, Cognition, and Dementia in primary care patients (1)

AgeCoDe

German study on Ageing, Cognition, and Dementia in primary care patients (2)

AgeCoDe

German study on Ageing, Cognition, and Dementia in primary care patients (3)

AGELESS

Multidomain Intervention for the Reversal of Cognitive Frailty Using a Personalized Approach

AGEN-T2D

Asian Genetic Epidemiology Network Type 2 Diabetes

AGENT

Angiogenic GENe Therapy

AGENT-2

Angiogene GENe Therapy-2: A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

AGENT-3

Angiogenic GENe Therapy-3: Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina

AGENT-4

Angiogenic GENe Therapy-4: Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina

AGENT-ISR

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis

AgeQualiDe

Bedarf und Inanspruchnahme von Versorgungsleistungen, direkte Kosten und gesundheitsbezogene Lebensqualität bei hochaltrigen Hausarztpatientinnen und -patienten (85+)

AGES

Aichi Gerontological Evaluation Study

AGGRASTENT

Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade

AGHLS

Amsterdam Growth and Health Longitudinal Study

AGILE

Adaptive Goals and Interventions for Lifestyle Enhancement

AGILE

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

AGILE CST-2

AGILE (Early Phase Platform Trial for COVID-19)

AGILE-ACCORD

A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19